Published online October 27, 2008
doi:10.1084/jem.20080990
The Journal of Experimental Medicine, Vol. 205, No. 12, 2703-2710
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Suzuki et al.
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA
Takuji Suzuki1,
Takuro Sakagami1,
Bruce K. Rubin5,
Lawrence M. Nogee6,
Robert E. Wood2,
Sarah L. Zimmerman3,
Teresa Smolarek3,
Megan K. Dishop7,
Susan E. Wert1,
Jeffrey A. Whitsett1,
Gregory Grabowski3,
Brenna C. Carey1,
Carrie Stevens4,
Johannes C.M. van der Loo4, and
Bruce C. Trapnell1,2,8
1 Division of Pulmonary Biology, 2 Division of Pulmonary Medicine, 3 Division of Human Genetics, and 4 Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
5 Departments of Pediatrics and Biomedical Engineering, Wake Forest University School of Medicine, Winston-Salem, NC 27157
6 Department of Pediatrics, Johns Hopkins University, Baltimore, MD 21205
7 Department of Pathology, Texas Children's Hospital, Houston, TX 77030
8 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267
CORRESPONDENCE Bruce C. Trapnell: Bruce.Trapnell{at}cchmc.org
Primary pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by accumulation of surfactant in the lungs that is presumed to be mediated by disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signaling based on studies in genetically modified mice. The effects of GM-CSF are mediated by heterologous receptors composed of GM-CSF binding (GM-CSF-R
) and nonbinding affinity-enhancing (GM-CSF-Rβ) subunits. We describe PAP, failure to thrive, and increased GM-CSF levels in two sisters aged 6 and 8 yr with abnormalities of both GM-CSF-R
–encoding alleles (CSF2RA). One was a 1.6-Mb deletion in the pseudoautosomal region of one maternal X chromosome encompassing CSF2RA. The other, a point mutation in the paternal X chromosome allele encoding a G174R substitution, altered an N-linked glycosylation site within the cytokine binding domain and glycosylation of GM-CSF-R
, severely reducing GM-CSF binding, receptor signaling, and GM-CSF–dependent functions in primary myeloid cells. Transfection of cloned cDNAs faithfully reproduced the signaling defect at physiological GM-CSF concentrations. Interestingly, at high GM-CSF concentrations similar to those observed in the index patient, signaling was partially rescued, thereby providing a molecular explanation for the slow progression of disease in these children. These results establish that GM-CSF signaling is critical for surfactant homeostasis in humans and demonstrate that mutations in CSF2RA cause familial PAP.
© 2008 Suzuki et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Out of breath: GM-CSFR
mutations disrupt surfactant homeostasis
- Luigi D. Notarangelo and Itai Pessach
J. Exp. Med. 2008 205: 2693-2697.
[Abstract]
[Full Text]
[PDF]